RT @guty2370: sino también ayudar a prevenir la aparición de PASC y aliviar la secuelas. https://t.co/b7UMWt60y8 https://t.co/oiCvZXRsqp
sino también ayudar a prevenir la aparición de PASC y aliviar la secuelas. https://t.co/b7UMWt60y8 https://t.co/oiCvZXRsqp
@seligerj @bryan_johnson Yup... And EBV can reactivate when you're under a lot of stress (such as during COVID-19) : https://t.co/KDfj3IJigc https://t.co/vicmjKNpof https://t.co/8xLk5mR1pO https://t.co/7xTDAcqXlu https://t.co/OwkeB1Avbu https://t.co/kGN
RT @mama_melaleuca: Long Covid患者において:T細胞の機能不全が継続している事を示す論文 https://t.co/nfFcDUwiGN 重症のCovid-19(新型コロナウイルス)において https://t.co/Hd3nM0NjsW EBV…
12/1 Mehrere frühe Faktoren lassen postakute COVID-19-Folgeerscheinungen erwarten: https://t.co/vQObmVs9Go
RT @fitterhappierAJ: In acute infection, EBV and CMV reactivate (reads go up) transiently in the immune dysregulated state in a recent publ…
RT @KashPrime: Papers that show continuing dysfunction in T-cells: In Long Covid patients: https://t.co/xyQ5rfpXf7 In severe Covid-19 dise…
@hyper1664 @C_Scheibenbogen @RWittenbrink Und da sich eben viele Internisten nicht auskennen, wird gar nicht erst getestet, ob eine Reaktivierung vorliegt. Ich glaube, dass die hohe Prävalenz in LC-Studien kein Zufall sind, ob bei Iwasaki oder https://t.co
Concerning lymphocytes, the persistence of a low level of naïve T cells https://t.co/4zcD0SkSYn and a high level of exhausted T cells "Multiple early factors anticipate post-acute COVID-19 sequelae" https://t.co/EStq4MqVrs was correlated with the pr
@nolimitjuni0r This study for example used cutting edge single cell “-omics” to do a pretty deep analysis of immune cells in people with long Covid https://t.co/XcPwHMJQTB
RT @Aguirre1Gustavo: Study confirms that the development of #LongCOVID is associated with the level of VIRAL LOAD in blood in the acute sta…
RT @EricTopol: New @CellCellPress An in-depth assessment of over 200 people identifies factors that may predict #LongCovid, including #SAR…
@PhillyPhile215 @ahhrrr @WildPersistence @ShaneyWright However, some of the pathobiology studies were excellent. My fave so far is this paper from @LabHeath, they did a pretty deep dive into immune cel function using single cell “-omics” analyses https://t
@ShaneyWright @MichaelPelusoMD This was a great multi-omics study looking at immune cells in the blood. I really hope @LabHeath continues with more fantastic long Covid studies like this! Maybe looking at biopsied tissues :) https://t.co/XcPwHMKoJ9
expressed, but also all the proteins and the epigenetic states in individual cells. This approach has already been used in some stellar long Covid studies to uncover differences in immune cell states, for example in these two studies https://t.co/XcPwHMJQT
@jessica_jnd9 @cjmaddison This is from last year… he also spoke at a RECOVER R3 seminar https://t.co/XcPwHMJQTB
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
コルチゾールの低値に関連して以前のツイートを紹介 cellに掲載された論文ではコロナ後遺症の中でもサブタイプによってはコルチゾールの低下が認められる事もある また、特に呼吸器症状がメインの場合と消化器症状がメインの場合では本質的に異なる病態であることを示唆 https://t.co/SxKgsM3uow
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @mama_melaleuca: Long Covid患者において:T細胞の機能不全が継続している事を示す論文 https://t.co/nfFcDUwiGN 重症のCovid-19(新型コロナウイルス)において https://t.co/Hd3nM0NjsW EBV…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @KashPrime: Papers that show continuing dysfunction in T-cells: In Long Covid patients: https://t.co/xyQ5rfpXf7 In severe Covid-19 dise…
@ASzigetvari @illsinger @rjf_berger @LandauDaniel @Igoe @HGrunbichler @WHO @cdc @CDCgov @doceos2 @Docypsilon @leixsa @longcovidAT @oeg_mecfs Around 31%–69% of COVID-19 patients suffer from post-acute sequelae of COVID-19 (PASC) (Groff et al., 2021), or lon
RT @KashPrime: Papers that show continuing dysfunction in T-cells: In Long Covid patients: https://t.co/xyQ5rfpXf7 In severe Covid-19 dise…
@ZBescheide @illsinger Around 31%–69% of COVID-19 patients suffer from post-acute sequelae of COVID-19 (PASC) (Groff et al., 2021), or long COVID,… https://t.co/rTMNzdk0Uh 10/
Remember my mantra "Viral load matters!" when people say "masks don't work perfectly so they're of no benefit"? Nailed it again. U don't want a persisting 'latent' virus. The time of day you're infected also multiplies your viral load. Avoid getting expo
RT @KashPrime: Papers that show continuing dysfunction in T-cells: In Long Covid patients: https://t.co/xyQ5rfpXf7 In severe Covid-19 dise…
RT @carpe_diem0820: 抗核自己抗体がCOVID-19罹患から回復後12カ月後に検出され、サイトカイン、炎症マーカー、Long COVID症状と関連 一方、罹患前の自己抗体や接種歴は不明で因果関係は評価できず Circulating anti-nuclear…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
@MarkkuPatynen @zin_zah @jantunen_matti @jukka235 @harrtohm Joku oikea virologi tietää paremmin, mutta käsittääkseni on jo pitkään arveltu että LC-oireet voisivat ainakin osalla ja osittain liittyä herpeksen yms. vanhojen lymyävien virusten aktivoitumiseen
This paper I am on as a coauthor made it to the finals of most impactful paper of the year! Vote here is this it’s worth a win: https://t.co/UVE3IsIWyD
RT @HelenChuMD: Hi everyone, our Cell paper identifying factors that predict long COVID is in the Final Four of Stat madness for impactful…
RT @HelenChuMD: Hi everyone, our Cell paper identifying factors that predict long COVID is in the Final Four of Stat madness for impactful…
RT @HelenChuMD: Hi everyone, our Cell paper identifying factors that predict long COVID is in the Final Four of Stat madness for impactful…
Hi everyone, our Cell paper identifying factors that predict long COVID is in the Final Four of Stat madness for impactful papers in the last year. https://t.co/VaG0OgyryM Please vote for us to win the championships! @isbsci @LabHeath https://t.co/mW3B
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @TeamPostX: Multiple early factors anticipate post-acute COVID-19 sequelae: In patients with gastrointestinal PASC, SARS-CoV-2-specific…
RT @MoeSalim88: @jrzygirlinfla @Dakota_150 No you're right, it's a study, so not really a finished product/test that can be used at clinics…
@jrzygirlinfla @Dakota_150 No you're right, it's a study, so not really a finished product/test that can be used at clinics/hospitals just yet. That's my understanding anyway. The study can be found here: https://t.co/TyaSM8SLdn
Multiple early factors anticipate post-acute COVID-19 sequelae https://t.co/OScWwa3mkm
RT @MarekSJF: "Multiple early factors anticipate post-acute COVID-19 sequelae" "We resolved four PASC-anticipating risk factors at the tim…
"Multiple early factors anticipate post-acute COVID-19 sequelae" "We resolved four PASC-anticipating risk factors at the time of initial COVID-19 diagnosis: type 2 diabetes, SARS-CoV-2 RNAemia, Epstein-Barr virus viremia, and specific auto-antibodies." h
RT @TeamPostX: Multiple early factors anticipate post-acute COVID-19 sequelae: In patients with gastrointestinal PASC, SARS-CoV-2-specific…
Multiple early factors anticipate post-acute COVID-19 sequelae: In patients with gastrointestinal PASC, SARS-CoV-2-specific and CMV-specific CD8+ T cells exhibited unique dynamics during recovery from COVID-19.@UKJ_Jena KIM IV https://t.co/Lsay3zg3Lz
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…
RT @EricTopol: It's complicated. High levels of autoantibodies have been demonstrated in some people with #LongCovid. https://t.co/NwXVISG…